drugset / Trial / NCT01073761

Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study

NCT01073761

Phase 1 Completed 25 enrolled St Stephens Aids Trust
NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to look at the levels of three HIV medications darunavir, ritonavir and atazanavir in the blood after the drug intake has been stopped in order to understand how long these drugs persist in blood for. The study will specifically look at these three drugs blood levels after taking them for 10 days everyday. The main objective is to provide information on the potential safety (in terms of preventing virological failure and the development of resistance)of delaying drug doses occasionally by providing information on the decline in drug concentration after dosing has stopped.

Timeline

Start
2010-04
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Atazanavir Other / unclassified 300 mg Oral
Subject Darunavir Small molecule 800 mg Oral
Subject Ritonavir Other / unclassified 100 mg Oral